BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12383023)

  • 1. Genetic polymorphisms of matrix metalloproteinases: functional importance in the development of chronic obstructive pulmonary disease?
    Wallace AM; Sandford AJ
    Am J Pharmacogenomics; 2002; 2(3):167-75. PubMed ID: 12383023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function.
    Joos L; He JQ; Shepherdson MB; Connett JE; Anthonisen NR; Paré PD; Sandford AJ
    Hum Mol Genet; 2002 Mar; 11(5):569-76. PubMed ID: 11875051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polymorphism in promoter regions of matrix metalloproteinases (MMP1, MMP9, and MMP12) in chronic obstructive pulmonary disease patients].
    Korytina GF; Akhmadishina LZ; Ianbaeva DG; Viktorova TV
    Genetika; 2008 Feb; 44(2):242-9. PubMed ID: 18619044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-Gene Interactions Between Glutathione S-Transferase M1 and Matrix Metalloproteinases 1, 9, and 12 in Chronic Obstructive Pulmonary Disease in Serbians.
    Stankovic M; Nikolic A; Nagorni-Obradovic L; Petrovic-Stanojevic N; Radojkovic D
    COPD; 2017 Dec; 14(6):581-589. PubMed ID: 28949773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of the MMP3, MMP9, ADAM33 and TIMP3 genes polymorphic markers with development and progression of chronic obstructive pulmonary disease].
    Korytina GF; Tselousova OS; Akhmadishina LZ; Victorova EV; Zagidullin ShZ; Victorova TV
    Mol Biol (Mosk); 2012; 46(3):487-99. PubMed ID: 22888638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on matrix metalloproteinase 1, 9, 12 polymorphisms and susceptibility to chronic obstructive pulmonary disease among Han nationality in northern China].
    Zhang RB; He QY; Yang RH; Lu BB; Liu YJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Nov; 26(11):907-10. PubMed ID: 16676616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of matrix metalloproteinases and protein levels in chronic obstructive pulmonary disease in a Mexican population.
    Hernández-Montoya J; Pérez-Ramos J; Montaño M; Ramírez-Venegas A; Sansores RH; Pérez-Rubio G; Velázquez-Uncal M; Camarena A; Ramos C; Falfán-Valencia R
    Biomark Med; 2015; 9(10):979-88. PubMed ID: 26439471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms.
    Ogata T; Shibamura H; Tromp G; Sinha M; Goddard KA; Sakalihasan N; Limet R; MacKean GL; Arthur C; Sueda T; Land S; Kuivaniemi H
    J Vasc Surg; 2005 Jun; 41(6):1036-42. PubMed ID: 15944607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population.
    Mirowska-Guzel D; Gromadzka G; Czlonkowski A; Czlonkowska A
    J Neuroimmunol; 2009 Sep; 214(1-2):113-7. PubMed ID: 19628284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in TIMP1 but not MMPs predict excess FEV1 decline in two general population-based cohorts.
    van Diemen CC; Postma DS; Siedlinski M; Blokstra A; Smit HA; Boezen HM
    Respir Res; 2011 Apr; 12(1):57. PubMed ID: 21524282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of a porcine emphysema model.
    Bruun CS; Jensen LK; Leifsson PS; Nielsen J; Cirera S; Jørgensen CB; Jensen HE; Fredholm M
    Lung; 2013 Dec; 191(6):669-75. PubMed ID: 24043489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
    Woo M; Park K; Nam J; Kim JC
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMP12, lung function, and COPD in high-risk populations.
    Elkington PT; Cooke GS
    N Engl J Med; 2010 Apr; 362(13):1241; author reply 1242. PubMed ID: 20357289
    [No Abstract]   [Full Text] [Related]  

  • 14. Matrix metalloprotease polymorphisms are associated with gas transfer in alpha 1 antitrypsin deficiency.
    McAloon CJ; Wood AM; Gough SC; Stockley RA
    Ther Adv Respir Dis; 2009 Feb; 3(1):23-30. PubMed ID: 19293200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-environment interaction between the MMP9 C-1562T promoter variant and cigarette smoke in the pathogenesis of chronic obstructive pulmonary disease.
    Stankovic M; Kojic S; Djordjevic V; Tomovic A; Nagorni-Obradovic L; Petrovic-Stanojevic N; Mitic-Milikic M; Radojkovic D
    Environ Mol Mutagen; 2016 Jul; 57(6):447-54. PubMed ID: 27270564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNP-SNP positive interaction between MMP2 and MMP12 increases the risk of COPD.
    Ganbold C; Jamiyansuren J; Munkhzorig E; Dashtseren I; Jav S
    PLoS One; 2024; 19(5):e0301807. PubMed ID: 38771844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population.
    Haq I; Chappell S; Johnson SR; Lotya J; Daly L; Morgan K; Guetta-Baranes T; Roca J; Rabinovich R; Millar AB; Donnelly SC; Keatings V; MacNee W; Stolk J; Hiemstra PS; Miniati M; Monti S; O'Connor CM; Kalsheker N
    BMC Med Genet; 2010 Jan; 11():7. PubMed ID: 20078883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase 3 polymorphisms as a potential marker of enhanced susceptibility to lung cancer in chronic obstructive pulmonary disease subjects.
    Brzóska K; Bartłomiejczyk T; Sochanowicz B; Cymerman M; Grudny J; Kołakowski J; Kapka-Skrzypczak L; Kruszewski M; Sliwiński P; Roszkowski-Śliż K
    Ann Agric Environ Med; 2014; 21(3):546-51. PubMed ID: 25292126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of matrix metalloproteinase-1 polymorphisms with risk of COPD and lung cancer and survival in lung cancer.
    Enewold L; Mechanic LE; Bowman ED; Platz EA; Alberg AJ
    Anticancer Res; 2012 Sep; 32(9):3917-22. PubMed ID: 22993337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alveolar macrophage proteinase/antiproteinase expression in lung function and emphysema.
    Ishii T; Abboud RT; Wallace AM; English JC; Coxson HO; Finley RJ; Shumansky K; Paré PD; Sandford AJ
    Eur Respir J; 2014 Jan; 43(1):82-91. PubMed ID: 23900981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.